Does your organization have the capacity for global expansion? As biotech and pharmaceutical companies pursue opportunity in maturing markets and emerging economies, they rely on commercial solutions to globally expand what has become an evolving vendor ecosystem. But opportunity has its price. Increasing the use of external resources to achieve clinical advancements and healthcare discoveries requires the best practices for managing the complexities of R&D and therapeutic innovation. Enterprises within the life sciences industries looking to squeeze the most out of their investments as they expand into new markets face the ultimate challenge: improve operational excellence to better deliver new therapies while minimizing and regulatory risk and cost.

As an industry actively transforming itself in the pursuit of reestablishing long term sustainability, life sciences organizations are just beginning to embrace true digital transformation. The goal is to deploy a more holistic strategy that supports a much broader organizational approach to transformation than the current incremental focus on near term technological innovation, operational efficiency and the externalization of non-core competencies common in industry transformation efforts today.

The process of making biologics requires scientists to take living cells and transform them into desirable, purified products. These processes are usually divided into two categories: upstream processes and downstream processes. The challenge of biologics is that they are inherently “difficult to characterize, produce, and reproduce than most traditional pharmaceuticals.” Moreover, slight changes in the quality of raw materials, temperature or other factors, can significantly affect the medicines’ “quality, safety, or efficacy.” Focusing on standardized upstream processing could improve the ability of companies to maximize their gains.

We’ve previously discussed how Millennials have transformed the CPG, food and beverage markets. From an intense focus on sustainability and eco-friendliness to an interest in a wider range of flavors, this consumer demographic has more than proven the power of their buying dollars. Now, we’re seeing their preferences affect a specific corner of the food market: snack products. Because Millennials tend to live active, on-the-go lifestyles, they don’t necessarily have time to sit down for a big meal. Instead, they often graze by eating smaller portions more frequently throughout the day. The proliferation of conveniently packaged foods on grocery stores reflects this trend. Despite their influence, however, we cannot concentrate solely on Millennials. The Baby Boomer generation remains a significant consumer base, and their overall desire for healthy-for-you products has also reached the snack food category. When combined with the Millennial preference toward foods with natural ingredients, is it any surprise that we’re witnessing a growing demand for organic food and snack products?

The following is a guest post by Thomas Bentz, who is part of the Brand Marketing team at Dassault Systèmes. To download the solution brief for One Lab ISE, click here. In today’s competitive environment, Life Sciences organizations need to optimize lab operations by improving efficiency while maximizing quality and […]

In what has become a familiar refrain, yet another laboratory has been cited by the Occupational Health & Safety Administration (OSHA) for major safety violations. This time around, the citations pertain to several issues including ones related to hazard communication, process safety information, process hazard analysis, contractor safety and written […]

Page 28 of 99« First...1020...2627282930...405060...Last »